Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (OP: MEDIF )

0.0579 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medipharm Labs Corp

< Previous 1 2 3 Next >
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. 
Via Benzinga
Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found
New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 23, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details
Cannabinoid-focused pharmaceutical company MediPharm Labs Corp. 
Via Benzinga
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status
MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed the US FDA drug API manufacturer inspection at the company's Barrie, Ontario... 
Via Benzinga
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 25, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Leadership Shake-Ups Across Several Weed Companies: Who Got The Top Jobs?
As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the marijuana 
Via Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. (OTCQB: MEDIF) for the commercialization of... 
Via Benzinga
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, May 22
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 16 stocks. 
Via Talk Markets
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth over the past two years and a significant reduction in losses to CA$2.1... 
Via Benzinga
Marijuana Stock Movers For August 9, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, April 14
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks. 
Via Talk Markets
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow 
Via Benzinga
Marijuana Stock Movers For August 8, 2023
Via Benzinga
The Canadian Cannabis Report - Monday, April 10
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks. 
Via Talk Markets
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021. 
Via Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
Via Benzinga
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
MediPharm Labs Corp. 
Via Benzinga
Cannabis Stock Movers For August 3, 2023
Via Benzinga
Marijuana Stock Movers For August 2, 2023
Via Benzinga
Marijuana Stock Movers For August 1, 2023
Via Benzinga
Cannabis Stock Movers For July 24, 2023
Via Benzinga
Cannabis Stock Movers For July 20, 2023
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.